相关实验视频
Updated: Jun 24, 2025

12:08
Diagonal Method to Measure Synergy Among Any Number of Drugs
Published on: June 21, 2018
18.5K
贝叶斯的方法来检测药物相互作用使用外部信息自发报告系统的药物相互作用.
Keisuke Tada1, Kazushi Maruo2, Masahiko Gosho2
1Biostatistics & Programming, Sanofi K.K, Shinjuku-ku, Tokyo, Japan.
Statistics in medicine
|June 6, 2024
概括
这项研究引入了一种新的贝叶斯方法,用于改进使用自发报告系统检测药物相互作用 (DDI) 诱导的不良药物反应 (ADR). 这种新方法提高了检测灵敏度,可以更早地识别潜在的安全问题.
科学领域:
- 药物监督 药物监督 药物监督
- 生物统计学 生物统计学
- 药品安全 药品安全
背景情况:
- 临床试验的安全评估对于已上市的药物来说是不够的.
- 单一药物和药物相互作用 (DDI) 的不良药物反应 (ADR) 需要持续监测.
- 自发报告系统 (SRS) 对于正在进行的药物安全评估至关重要.
研究的目的:
- 提出一种新的贝叶斯法,用于在SRS数据库中检测潜在的DDI.
- 与现有方法相比,提高DDI检测的灵敏度.
- 为了能够更早地识别潜在的DDI.
主要方法:
- 开发一种贝叶斯方法,利用DDI检测之前的功率.
- 从类似药物借取信息,以提高检测灵敏度.
- 在调整信息借用之前,在功率内调整参数.
主要成果:
- 模拟研究表明,检测灵敏度显著增加,达到大约20个点.
- 拟议的方法显示了早期检测DDI的潜力.
- 对食品和药物管理局 (FDA) 数据库的分析支持了早期检测能力.
结论:
- 新的贝叶斯方法为检测潜在的DDI提供了更高的灵敏度.
- 引入了早期DDI检测的新标准.
- 该方法的有效性取决于具有类似观察到预期比率的类似药物.
相关概念视频
Pharmacovigilance
825
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
825
Drug-Receptor Interactions
5.1K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
5.1K
Combined Effects of Drugs: Synergism
3.8K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.8K
Quantitative Aspects of Drug-Receptor Interaction
973
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
973
Drug-Receptor Interaction: Antagonist
2.9K
An antagonist is a drug that binds strongly to a receptor without activating it. An antagonist prevents other molecules, such as neurotransmitters or hormones, from binding to the receptor and triggering a cellular response. Such interaction effectively hinders the normal physiological processes mediated by the receptor, resulting in various pharmacological effects depending on the specific receptor targeted.
Antagonists can be classified as competitive or noncompetitive based on their...
Antagonists can be classified as competitive or noncompetitive based on their...
2.9K
Drug-Receptor Interaction: Agonist
2.5K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
2.5K

